Addressing an Unmet Need in EGFR mNSCLC

F

PAPILLON Trial Results: Amivantamab + Chemo vs. Chemo as 1L Treatment in EGFR exon 20 Insertion-Mutated Advanced NSCLC

By Filippo de Marinis 6 Videos
271 views
May 16, 2024
Comments 0
Login to view comments. Click here to Login
10:18

Current Recommendations on Managing Dermatologic Adverse Reactions A…

Fawzi Abu Rous

270 views
13:49

The Importance of Staying on Therapy for EGFR exon 20 NSCLC

Giri Raval

229 views
11:39

ELCC 2024 Insights: "Small Numbers, Big Impact - The Importance of T…

Insights from ELCC 2024

L. Brcic

285 views
06:41

ELCC 2024 Insights: "The Frequency of Occurrence of EGFR PACC Mutati…

Insights from ELCC 2024

X. Le

234 views
08:30

PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EG…

Insights from 2023 ESMO Annual Meeting

N. Girard

838 views
17:34

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

909 views
26:21

NSCLC & Targeted Therapy: A Brief Overview and Update in the Metasta…

Memorial Sloan Kettering Cancer Center

M. Hwang

1.0K views